Paradigm: towards an integrated platform for registration of patients in clinical trials.
A generalised registration-randomisation package, known as paradigm, has been developed by the Netherlands Cancer Institute and the MRC Cancer Trials Office initiated in association with the EORTC within the EuroCODE project and partially funded by the European Community. This randomisation software takes into account requirements of four major data centres in Belgium, France, The Netherlands and the UK and is suitable for use at further European Clinical Trial data centres to enable remote entry of patients into trials. The system became operational at the start of 1994, and is now in use at three hospitals and data centres.
Dalesio
O
O
Biometrics Department, Netherlands Cancer Institute, Amsterdam.
Jenkin
L
L
van der Donk
E
E
D003627:Data Interpretation, Statistical; D005062:European Union; D006801:Humans; D018579:Patient Selection; D011785:Quality Assurance, Health Care; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D012984:Software